The Pharmaceutical Studies Reader (Wiley Blackwell Readers in Anthropology)

The Pharmaceutical Studies Reader is an engaging survey of the field that brings together provocative, multi-disciplinary scholarship examining the interplay of medical science, clinical practice, consumerism, and the healthcare marketplace. * Draws on anthropological, historical, and sociological approaches to explore the social life of pharmaceuticals with special emphasis on their production, circulation, and consumption * Covers topics such as the role of drugs in shaping taxonomies of disease, the evolution of prescribing habits, ethical dimensions of pharmaceuticals, clinical trials, and drug research and marketing in the age of globalization * Offers a compelling, contextually-rich treatment of the topic that exposes readers to a variety of approaches, ideas, and frameworks * Provides an accessible introduction for readers with no previous background in this area

Sergio Sismondo is Professor of Philosophy and Sociology at Queen's University, Canada. His current work, including a number of recent articles, explores the pharmaceutical industry's development and deployment of clinical research, focusing on intersections of marketing and science. He is the author and co-author of a number of books, including An Introduction to Science and Technology Studies, Second Edition (Wiley Blackwell, 2010) and The Art of Science (2003). He is Editor of the journal Social Studies of Science. Jeremy A. Greene is Elizabeth Treide and A. McGehee Harvey Chair in the History of Medicine at Johns Hopkins University. His recent work focuses on the ways in which the development and consumption of therapeutics interact with our understandings of what it means to be sick or healthy, normal or abnormal. His broader research interests focus on the history of disease, the history of global health, and the history of the pharmaceutical industry and its interactions with medical research, clinical practice, and public health. He is the author of Generic: The Unbranding of Modern Medicines (2014) and Prescribing by Numbers: Drugs and the Definition of Disease (2007), as well as co-editor of Prescribed: Writing, Filling, Using, and Abusing the Prescription in Modern America (2012).

Acknowledgements vii 1 Introduction 1 Jeremy A. Greene and Sergio Sismondo Part I Pharmaceutical Lives 17 2 The Pharmaceuticalisation of Society? A Framework for Analysis 19 Simon J. Williams, Paul Martin and Jonathan Gabe 3 Pharmaceutical Witnessing: Drugs for Life in an Era of Direct?]to?]Consumer Advertising 33 Joseph Dumit Part II New Drugs, Diseases, and Identities 49 4 Releasing the Flood Waters: Diuril and the Reshaping of Hypertension 51 Jeremy A. Greene 5 Dep(r)ession and Consum??tion: Psychopharmaceuticals, Branding, and New Identity Practices 70 Nathan Greenslit 6 BiDil: Medicating the Intersection of Race and Heart Failure 87 Anne Pollock 7 Manufacturing Desire: The Commodification of Female Sexual Dysfunction 106 Jennifer R. Fishman Part III Drugs and the Circulation of Medical Knowledge 121 8 Following the Script: How Drug Reps Make Friends and Influence Doctors 123 Adriane Fugh?]Berman and Shahram Ahari 9 Getting to Yes: Corporate Power and the Creation of a Psychopharmaceutical Blockbuster 133 Kalman Applbaum 10 Pushing Knowledge in the Drug Industry: Ghost?]Managed Science 150 Sergio Sismondo 11 Transcultural Medicine: A Multi?]Sited Ethnography on the Scientific?]Industrial Networking of Korean Medicine 165 Jongyoung Kim Part IV Political and Moral Economies of Pharmaceutical Research 179 12 Uncommon Trajectories: Steroid Hormones, Mexican Peasants, and the Search for a Wild Yam 181 Gabriela Soto Laveaga 13 "Ready?]to?]Recruit" or "Ready?]to?]Consent" Populations? Informed Consent and the Limits of Subject Autonomy 195 Jill A. Fisher 14 Clinical Trials Offshored: On Private Sector Science and Public Health 208 Adriana Petryna 15 The Experimental Machinery of Global Clinical Trials: Case Studies from India 222 Kaushik Sunder Rajan Part V Intellectual Property in Local and Global Markets 235 16 Intellectual Property and Public Health: Copying of HIV/AIDS Drugs by Brazilian Public and Private Pharmaceutical Laboratories 237 Maurice Cassier and Marilena Correa 17 Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis' Anti?]Cancer Drug Glivec 247 Stefan Ecks 18 Generic Medicines and the Question of the Similar 261 Cori Hayden Index 268